Aurobindo Pharma Reports 4% Rise in Q2 Net Profit to ₹848 Crore
Aurobindo Pharma has announced a 4% increase in its net profit for the second quarter, reaching ₹848 crore. The company’s financial performance reflects steady growth amid competitive market conditions. Aurobindo Pharma posts a 4% increase in net profit for Q2 2025-26, reaching ₹848 crore amid strong sales in domestic and international markets. Hyderabad-based pharmaceutical company…